The incidence and severity of Clostridium difficile infections are increasing, and several antibiotics are available for treatment. This comparative effectiveness review of 11 randomized trials involving adults with C. difficile found that initial cure rates did not significantly differ for fidaxomicin, vancomycin, and metronidazole. Recurrent disease was common with all agents but less frequent with fidaxomicin (15%) than with vancomycin (25%). Any of several agents could be used for initial treatment of C. difficile infection, but fidaxomicin may be a superior agent for recurrent infection.
Topics:
vancomycin, clostridium difficile infection, diarrhea, metronidazole, toxins, infection, antimicrobials, comparative effectiveness research, ...
Ann Intern Med. 2011;155(12):839-847. doi:10.7326/0003-4819-155-12-201112200-00007